Inflammatory Bowel Disease Industry Research PowerPoint PPT Presentations

Global tumor necrosis factor (TNF) inhibitor drugs market is expected to rise to an estimated value of USD 182.27 billion by 2026, registering a healthy CAGR in the forecast period of 2019-2026. Rising cases of Crohn’s disease and increasing demand for effective treatment are the major factor for the growth of this market.

Inflammatory Bowel Disease Market Size is estimated to reach $26.3 billion by 2027 and is poised to grow at a CAGR of 5.9% over the forecast period of 2022-2027. Inflammatory bowel disease (IBD) is an umbrella term used to describe disorders that involve chronic inflammation of the digestive tract. It includes ulcerative colitis, a condition in which inflammation and soreness of the superficial lining of the rectum and colon, and in Crohns disease affect any part of the gastrointestinal tract.

Inflammatory Bowel Disease Treatment Market: Information by Drug Class Disease Indication Distribution Channel, End-User—Forecast 2027

Big Market Research “Global Inflammatory Bowel Disease Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast. Visit for more info @ http://www.bigmarketresearch.com/global-inflammatory-bowel-disease-2015-2019-market Inflammatory bowel disease is a condition includes a group of autoimmune diseases such as Crohn's disease and ulcerative colitis. It causes chronic inflammation of a specific part or the entire GI tract. Both Crohn's disease and ulcerative colitis include symptoms such as severe persistent diarrhea, abdominal cramps and pain, rectal bleeding, fatigue, and weight loss.

The inflammation in Crohn's disease affects various areas of the GI tract such as the large intestine and small intestine, or both. Inflammatory bowel disease is a chronic medical condition, which has no permanent cure and demands a lifetime of treatment and management. The preferred treatment options include anti-inflammatory steroidal products and immuno-suppressive agents such as the TNF-α inhibitors. Analysts forecast the Global Inflammatory Bowel Disease market to grow at a CAGR of 3.95 percent over the period 2014-2019. Read more details at: http://www.bigmarketresearch.com/global-inflammatory-bowel-disease-2015-2019-market

Download Sample Brochure @ http://tinyurl.com/jcllyxb Marketintelreports, ‘Inflammatory Bowel Disease - Pipeline Review, H2 2015’, provides an overview of the Inflammatory Bowel Disease’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Inflammatory Bowel Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Inflammatory Bowel Disease and special features on late-stage and discontinued projects.

Inflammation is an action of the body’s immunity system to recover the injured tissues. However, inflammatory diseases are the diseases wherein this action of the immunity system gets compromised. Thus, inflammatory diseases in turn could lead to life threatening diseases as cancer and rheumatoid arthritis.

Global inflammatory disease drug delivery market is set to witness a substantial CAGR of 7.8% in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. Increasing cases of inflammatory diseases among population is the major factor for the growth of this market.

Food Research Lab is one of the leading food industry consultants and offers various food production services. We provide food production and food manufacturing consultancy services to food, beverage and nutraceutical companies. Primary food production involves everything from food procurement, inventory control, quality checks to processing. More info https://www.foodresearchlab.com/blog/nutraceutical-product/basics-elements-of-food-production-and-food-business/ Contact Us UK- +44 161 394 1144 India - +91 9566299022 Mail Id: info@foodresearchlab.com

According to the latest research report by IMARC Group, The global autoimmune disease diagnosis market size reached US$ 3.5 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 5.1 Billion by 2027, exhibiting a growth rate (CAGR) of 6.4% during 2022-2027. More Info:- https://www.imarcgroup.com/autoimmune-disease-diagnosis-market

According to the latest report by Renub Research, The global autoimmune disease diagnostic market is expected to surpass US$ 18 Billion by the year end of 2025. Forecast for (2019 -2025). Contact a Sample Report at info@renub.com

Inflammation is an action of the body’s immunity system to recover the injured tissues. However, inflammatory diseases are the diseases wherein this action of the immunity system gets compromised. Thus, inflammatory diseases in turn could lead to life threatening diseases as cancer and rheumatoid arthritis. https://www.databridgemarketresearch.com/reports/global-inflammatory-disease-drug-delivery-market

Inflammation is an action of the body’s immunity system to recover the injured tissues. However, inflammatory diseases are the diseases wherein this action of the immunity system gets compromised. Thus, inflammatory diseases in turn could lead to life threatening diseases as cancer and rheumatoid arthritis.

Autoimmune diseases develop when body’s immune system recognizes the healthy body cells as foreign cells, and when immune system produces auto-antibodies that attack and destroy healthy tissues in the body rather than infectious agents. The disease is the hyperactive immune response against the substances and tissues normally present in the body and these are generally caused by genetic, infectious or environmental factors. It may lead to abnormal organ growth and changes in the functions of the organs.

Crohn's Disease Diagnostic Market Report covers the whole Industry outlook, product types and applications. It covers the costing, sales, revenue details and forecasts of top players. It provides the forecast by type and by application. This report focuses on sales, market share and growth rate in each application and product type.

Innovative treatments are being developed by researchers, who are mainly focusing on reducing inflammation by using immunosuppressive therapies. Although these treatments promise remission in patients, risk of complications or relapse from long-lasting therapy prevail as key concerns. Significant improvements in the healthcare industry will stimulate in dealing with the rising instances regarding rare inflammatory diseases.

Global autoimmune disease treatment market is set to witness a substantial CAGR of 7.60% in the forecasted period of 2019-2026. This rise in the market can be attributed due to enhancement in autoimmune diagnosis and technology advancement in the industry.

Identification of new agents is done in order to develop treatments for multiple inflammatory diseases, which share common pathways

Conduct clinical trials for acute diarrhea ... Mutual funding of multicenter trials for therapies of NEC ... Conduct clinical trials to compare multimodality ...

Big Market Research has announced a new Report Package "Global Irritable Bowel Syndrome Market -Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential" Get Complete Details At: http://www.bigmarketresearch.com/global-irritable-bowel-syndrome-2015-2019-market Irritable bowel syndrome is a common disorder of the digestive system causing abdominal cramps, discomfort, bloating, constipation, and diarrhea. Inflammatory bowel disease, which is a chronic disease with recurrent immune response and inflammation of the GI tract, is sometimes confused with irritable bowel syndrome. Enquire About this report At: http://www.bigmarketresearch.com/report-enquiry/169977

Gastrointestinal diseases include conditions such as gastroesophageal reflux disease, inflammatory bowel disease, Crohn’s disease, peptic ulcer disease, irritable bowel syndrome, gastric cancer, ulcerative colitis and others.

Global Gastrointestinal Diseases Drug Development Market will exhibit a CAGR of around 6.90% for the forecast period of 2021-2028. From the name itself, it is clear that gastrointestinal diseases are the diseases related to the gastrointestinal tract. A few examples of gastrointestinal diseases are constipation, inflammatory bowel diseases, irritable bowel syndrome, colitis, and so on. Get Full Access of Report @ https://www.databridgemarketresearch.com/reports/global-gastrointestinal-diseases-drug-development-market

Autoimmune Diseases Market

Ulcerative Colitis (Colitis ulcerosa or UC) is a chronic disease mainly of the large intestine or colon and a type of Inflammatory Bowel Disease (IBD). The disease is characterized by open sores and ulcers in the colon. 

The disease is highly prevalent in developed countries, especially in individuals who smoke. According to a study conducted by Persistence Market Research (PMR), demand for anti-inflammatory drugs and biologics for treating Crohn’s disease will gain traction in the near future. PMR forecasts that the global market for Crohn’s disease is set to reach US$ 4,474.8 Million by 2024-end, growing at a CAGR of 3% during the assessment period.

The global budesonide market size was is accounted to register a sustainable CAGR of 5.4% during the forecast period 2021 to 2027 and expected to reach at USD 4,260 million by 2027. Rising prevalence of pulmonary complication worldwide primarily drives the budesonide market growth. Additionally, positive results obtained from clinical trial investigation of budesonide in the treatment of inflammatory bowel disease further accentuates its market growth.

According to Crohn’s & Colitis UK, around 300,000 people suffer from crohn’s disease and ulcerative colitis in the UK annually.[1] Malnourishment is the common cause of inflammatory bowel disease (IBD) among a large section of people in both under-developed and developing countries.

Microbiome Therapeutics Market, by Types (Fecal Microbial Technology (FMT), Drugs), Applications (Diabetes, Inflammatory Bowel Disease, Multiple Sclerosis, Rheumatoid Arthritis, Others) - Global Revenue, Trends, Growth, Share, Size, and Forecast to 2022

The Business Research Company offers ostomy drainage bags market research report 2023 with industry size, share, segments and market growth

The ostomy drainage bags market was valued at $2,742 million in 2015, and is expected to reach $3,524 million by 2022, growing at a CAGR of 3.6% from 2016 to 2022.High prevalence of colorectal cancer owing to the increase in geriatric population drives the market growth. Increase in population prone to colon cancer, urinary tract cancer, bladder cancer, colorectal cancer, inflammatory bowel disease, and chronic diseases such as ulcerative colitis and Crohns disease that require ostomy surgery, further boosts the market growth.

The report on Gastrointestinal Drugs Market by category(acid neutralizers, antidiarrheal & laxatives, anti-inflammatory), route of administration(oral, parenteral, rectal), disease type(gastro-esophageal reflux disorder, inflammatory bowel disease) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Gastrointestinal Drugs Market is projected to grow at a CAGR between 4.5 % to 5.0% in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.

The global bowel obstruction market is significantly growing over the past few years. An increase in the prevalence of gastrointestinal diseases is the major factor driving the revenue growth of the market. According to the National Institute of Diabetes and Digestive and Kidney Diseases, in 2020, about 70 million people in the US were suffering from gastrointestinal issues and this number is expected to increase in the coming years.

The Asia-Pacific anti-inflammatory therapeutics market is expected to grow at a CAGR of 8.6% over the forecast period, owing to the rising healthcare expenditure, disposable income of individuals, increasing popularity of biologics and better healthcare access. Increase in the number of autoimmune and respiratory diseases, new drugs in development pipeline and increased usage of OTC NSAIDs are the major factors driving the Asia-Pacific anti-inflammatory market. Read Complete Report @ http://www.researchbeam.com/anti-inflammatory-therapeutics-market On the basis of drug class, the market is segmented into anti-inflammatory biologics, non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids. Enquire @ http://www.researchbeam.com/anti-inflammatory-therapeutics-market/enquire-about-report

The autoimmune disease treatment market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to grow at a CAGR of 7.60% in the above-mentioned forecast period. Increasing awareness regarding healthcare sector drives the autoimmune disease treatment market. https://www.databridgemarketresearch.com/reports/global-autoimmune-disease-treatment-market

Inflammation extends deeper into the lining of the intestine and usually occurs ... in Scandinavian Countries and Scotland followed by England and North America ...

According to the National Institutes of Health (NIH), around 23.5 million Americans are suffering from autoimmune disease.

Big Market Research “Global Colorectal Cancer Drugs Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/global-colorectal-cancer-drugs-2015-2019-market Colorectal cancer refers to malignancies that originate in the rectum or the colon. It is also known as bowel cancer. Formation of adenocarcinomas is the most common feature of colorectal cancer. The cancer starts as a polyp in the inner wall of the colon or rectum. These polyps can be benign or malignant. Colorectal cancer is the third most common cancer in the US.

The report “Global Ostomy Market: Industry Analysis & Outlook (2017-2021)” by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook.

The global autoimmune disease therapeutics market was valued at $109,833 million in 2017, and is projected to reach $153,320 million by 2025, registering a CAGR of 4.2% from 2018 to 2025.

Global ostomy drainage bags market size is expected at $2.55 Bn by 2027 at a growth rate of 3.6% and outlook by The Business Research Company.

The global ostomy drainage bags market was valued at $1,658.38 million in 2020, and is projected to reach $2,409.38 million by 2030, growing at a CAGR of 3.8% from 2021 to 2030.

The Business Research Company offers biosimilar interleukins market research report 2023 with industry size, share, segments and market growth

Anti-Inflammatory Therapeutics Market

Most people think of calcium & bones as health benefits of dairy. ... fruits, vegetables and low-fat dairy reduces BP in people with mild hypertension ...

The probiotic Ingredients in Human Nutrition Market is anticipated to grow at a CAGR of around 8.4 % during the forecast period, i.e., 2022-27. The mounting trend of probiotic ingredients in dietary supplements to prevent gastrointestinal issues & cardiovascular diseases drives the market. Read More: https://www.marknteladvisors.com/query/request-sample/global-probiotics-ingredients-in-human-nutrition-market.html

The pharmaceutical suppositories market size was valued at $1.6 billion in 2022, and is estimated to reach $2.8 billion by 2032, growing at a CAGR of 5.7% from 2023 to 2032. Pharmaceutical suppositories, though not a novel concept, have gained momentum in recent years due to their advantages over traditional drug delivery methods. These solid or semi-solid formulations, designed for insertion into the rectum, vagina, or urethra, offer localized and systemic therapeutic effects. The ease of administration, avoidance of first-pass metabolism, and improved bioavailability are some of the key factors contributing to their rising popularity. Know More- https://www.alliedmarketresearch.com/pharmaceutical-suppositories-market-A12350

Global colorectal cancer molecular diagnostics market size is expected to reach $3.48 Bn by 2028 at a rate of 8.0%, segmented as by type, instruments, reagents and kits, services

The global autoimmune disease diagnostics market size was valued at USD 4,253.29 million in 2021 and is anticipated to generate 8089.97 million by 2030.

This market research report on Visceral Pain market offers analysis on market size & forecast, share, industry trends, growth drivers, and vendor analysis during 2018 to 2025.

Complete Report @ http://goo.gl/w0EkdC "The Human Microbiome: Biomedical Implications and Birth of a Market" report covers the evolution of microbiome research and its growth in the commercial market. Specific areas of study include microbial ecology, systems biology, diet, diagnostics, contributions in health and disease, and infectious disease.

According to the latest research report by IMARC Group, The global probiotic dietary supplement market size reached US$ 6.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.2 Billion by 2028, exhibiting a growth rate (CAGR) of 6.1% during 2023-2028. More Info:- https://www.imarcgroup.com/probiotic-dietary-supplement-market

Global autoimmune disease treatment market is set to witness a substantial CAGR of 7.60% in the forecasted period of 2019-2026. This rise in the market can be attributed due to enhancement in autoimmune diagnosis and technology advancement in the industry.

The United States has the highest incidence of autoimmune diseases; about 50 million patients are suffering from this disease. Autoimmune Disease Diagnostic Market is forecasted to exceed US$ 18 Billion by the end of the year 2025.

Major players in the interleukin inhibitors market are Sanofi, GlaxoSmithKline, Novartis, Johnson & Johnson, Roche, Eli Lilly, AstraZeneca..... @ @ https://bit.ly/3rLoTDG

Looking forward, the autoimmune disease diagnosis market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/autoimmune-disease-diagnosis-market

Major players in the TNF alpha inhibitors market are AbbVie Inc., Amgen Inc., Johnson & Johnson Services, Inc., UCB S.A, Novartis International AG... @ @ https://bit.ly/3h9buRa